Yellow fever in South America – A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN
Alfonso J. Rodríguez‐Morales(Technological University of Pereira), Gustavo A. Grandez-Castillo(National University of San Marcos), Germán Arrieta(Asociación Colombiana de Infectología), Asma Al Balushi(Sultan Qaboos University Hospital), Daniele Fasan, Álvaro A. Faccini‐Martínez(Military University Nueva Granada), Cecilia Perret, Balram Rathish(Imperial College Healthcare NHS Trust), Ayşegül Taylan Özkan(Cyprus International University), Alex Julián Forero-Delgadillo(Centro Dermatológico Federico Lleras Acosta), Ferenc Balázs Farkas(Semmelweis University), Christian Wejse(Aarhus University), A. Fuster(Fundación para las Relaciones Internacionales y el Diálogo Exterior), Bhanasut Hunsajarupan(Ministry of Public Health), Aayush Adhikari(Tribhuvan University Teaching Hospital), Amanda Guerrero(Instituto de Medicina Tropical), Marta Sanz(Instituto Cajal), D. Katterine Bonilla‐Aldana(Secretaría Nacional de Ciencia, Tecnología e Innovación), Alejandro Rísquez(Central University of Venezuela), Alexis Holguín(Instituto Nacional de Enfermedades Neoplásicas), Botond Lakatos(Semmelweis University), Corneliu Petru Popescu(Carol Davila University of Medicine and Pharmacy), Aula Abbara(St Mary's Hospital), Emanuele Pontali(Ente Ospedaliero Ospedali Galliera), Francisco Javier Membrillo de Novales(Hospital Central de la Defensa Gómez Ulla), David de Luna(Pontificia Universidad Católica Madre y Maestra), Giacomo Guido(University of Bari Aldo Moro), Edward J M Monk(London School of Hygiene & Tropical Medicine), Alejandro Lepetic(GlaxoSmithKline (Brazil)), Emmanuel O. Ngbede(Institute of Medical Microbiology and Hygiene), Carlos Álvarez(Universidad Nacional de Colombia), Abdulaziz Alhazmi(Jazan University), Eirini Iliaki(Cambridge Health Alliance), Cristián Biscayart(Fundación Centro de Estudios Infectológicos), Caroline Rönnberg(Karolinska University Hospital), Francesco Di Gennaro(University of Bari Aldo Moro), Francesca Norman(Instituto Cajal), Francesca Mariotti(Azienda Usl Toscana Centro), Diogo Mendes Pedro(Administração Regional de Saúde de Lisboa e Vale do Tejo), Florencia Escarrá(Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno), Ana Freitas Ribeiro(Instituto de Infectologia Emílio Ribas), Alejandra Morales(Administración Nacional de Laboratorios e Institutos de Salud), Beatriz Elena Porras-Pedroza(Fundación Universitaria Sanitas), Abraham Katime(University of Magdalena), Diana Isabela Costescu-Strachinaru(Queen Astrid Military Hospital), Baruch Diaz(Universidad Nacional Autónoma de México), Ahneez Abdul Hameed(Hospital Selayang)
Cited by 13
Related Papers
Going global – Travel and the 2019 novel coronavirus
|Travel Medicine and Infectious Disease|2020|376
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226
The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI)
|Travel Medicine and Infectious Disease|2020|197
Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review
|Travel Medicine and Infectious Disease|2020|151
Zika among international travellers presenting to GeoSentinel sites, 2012–2019: implications for clinical practice
|Journal of Travel Medicine|2020|143